[Serological markers of selected viral infections transmitted by parenteral route in drug addicts]. 1991

W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
Klinika Chorób Zakaźnych Akademii Medycznej, Bydgoszczy.

Investigations included a group 80 asymptomatic drug addicts. They were examined immunoenzyme method aiming at detection infection by HIV, HBV, HCV and HDV. Cases of seropositive HIV results were confirmed by means WB. In 68 examined patients serological evidence of virus HBV was discovered. In 60 of them one also found out coexisting HIV serological markers, in 51 of HCV markers. HDV antibodies were disclosed in 7 cases. Infection with hepatotropic viruses were more frequent in group of HIV(+) drug addicts.

UI MeSH Term Description Entries
D008297 Male Males
D011044 Poland A country in central Europe, east of Germany. The capital is Warsaw. Polish People's Republic,Republic of Poland
D003698 Hepatitis Delta Virus A defective virus, containing particles of RNA nucleoprotein in virion-like form, present in patients with acute hepatitis B and chronic hepatitis. It requires the presence of a hepadnavirus for full replication. This is the lone species in the genus Deltavirus. Delta Agent,Delta Virus,Deltavirus,Hepatitis D Virus,Delta Agents,Delta Virus, Hepatitis,Delta Viruses,Delta Viruses, Hepatitis,Deltaviruses,Hepatitis D Viruses,Hepatitis Delta Viruses
D003699 Hepatitis D INFLAMMATION of the LIVER in humans caused by HEPATITIS DELTA VIRUS, a defective RNA virus that can only infect HEPATITIS B patients. For its viral coating, hepatitis delta virus requires the HEPATITIS B SURFACE ANTIGENS produced by these patients. Hepatitis D can occur either concomitantly with (coinfection) or subsequent to (superinfection) hepatitis B infection. Similar to hepatitis B, it is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Amazon Black Fever,Black Fever, Amazon,Delta Hepatitis,Delta Infection,Delta Superinfection,Hepatitis, Delta,Labrea Disease,Infection, Delta,Superinfection, Delta,Delta Superinfections,Disease, Labrea,Diseases, Labrea,Fever, Amazon Black,Hepatitides, Delta,Infections, Delta,Labrea Diseases,Superinfections, Delta
D005260 Female Females
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
January 1989, Enfermedades infecciosas y microbiologia clinica,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
January 1961, Studii si cercetari de inframicrobiologie,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
January 1999, Terapevticheskii arkhiv,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
January 1983, Scandinavian journal of infectious diseases,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
January 2009, Georgian medical news,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
January 1991, Acta medica portuguesa,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
March 1985, Medicina clinica,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
September 1987, Medicina clinica,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
January 1999, Voprosy virusologii,
W Halota, and J Opoka, and J Trzciński, and M Dorau, and E Topczewska, and W Giziński, and F Bulik
October 1983, Israel journal of medical sciences,
Copied contents to your clipboard!